References
- Jackson SP (2011) Arterial thrombosis--insidious, unpredictable and deadly. Nat Med 17: 1423-1436 https://doi.org/10.1038/nm.2515
- Schwartz SM, Heimark RL, Majesky MW (1990) Developmental mechanisms underlying pathology of arteries. Physiol Rev 70: 1177-1209 https://doi.org/10.1152/physrev.1990.70.4.1177
- Payrastre B, Missy K, Trumel C, Bodin S, Plantavid M, Chap H (2000) The integrin alpha IIb/beta 3 in human platelet signal transduction. Biochem Pharmacol 60(8): 1069-1074 https://doi.org/10.1016/S0006-2952(00)00417-2
- Morello F, Perino A, Hirsch E (2009) Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res 82(2): 261-271 https://doi.org/10.1093/cvr/cvn325
- Jennings LK (2009) Role of platelets in atherothrombosis. Am J Cardiol 103: 4A-10A https://doi.org/10.1016/j.amjcard.2008.11.017
- Sabatine MS, Jang IK (2000) The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. Am J Med 109(3): 224-237 https://doi.org/10.1016/S0002-9343(00)00474-5
- Cattanco M, Tenconi PM, Lecchi A, Mannucci PM (1991) In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Thromb Res 62: 717-724 https://doi.org/10.1016/0049-3848(91)90375-7
- Su CY, Shiao MS, Wang CT (1999) Differential effects of ganodermic acid S on the thromboxane A2-signaling pathways in human platelets. Biochem Pharmacol 58: 587-595 https://doi.org/10.1016/S0006-2952(99)00136-7
- Adam F, Kauskot A, Rosa JP, Bryckaert M (2008) Mitogenactivated protein kinases in hemostasis and thrombosis. J Thromb Haemost 6: 2007-2016 https://doi.org/10.1111/j.1538-7836.2008.03169.x
- Bugaud F, Nadal-Wollbold F, Levy-Toledano S, Rosa JP, Bryckaert M (1990) Regulation of c-jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood 94: 3800-3805 https://doi.org/10.1182/blood.v94.11.3800.423k25_3800_3805
- Kramer RM, Roberts EF, Strifler BA, Johnstone EM (1995) Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem 270: 27395-27398 https://doi.org/10.1074/jbc.270.46.27395
- Nadal-Wollbold F, Pawlowski M, Levy-Toledano S, Berrou E, Rosa JP, Bryckaert M (2002) Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf. FEBS Lett 531: 475-482 https://doi.org/10.1016/S0014-5793(02)03587-1
- Patrono C (1994) Aspirin as an antiplatelet drug. N Engl J Med 330: 1287-1294 https://doi.org/10.1056/NEJM199405053301808
- Flevaris P, Li Z, Zhang G, Zheng Y, Liu J, Du X (2009) Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. Blood 113: 893-901 https://doi.org/10.1182/blood-2008-05-155978
- Kramer RM, Roberts EF, Um SL, Borsch-Haubold AG, Watson SP, Fisher MJ, Jakubowski JA (1996) p38 mitogenactivated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombinstimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J Biol Chem 271: 27723-27729 https://doi.org/10.1074/jbc.271.44.27723
- McNicol A, Shibou TS (1998) Translocation and phosphorylation of cytosolic phospholipase A2 in activated platelets. Thromb Res 92: 19-26 https://doi.org/10.1016/S0049-3848(98)00097-8
- Chuang WY, Kung PH, Kuo CY, Wu CC (2013) Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidylinositol 3-kinase/Akt pathway, Thromb. Haemost 109(6): 1120-1130 https://doi.org/10.1160/TH12-09-0636
- Huang HC, Chu SH, Chao PD (1991) Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur J Pharmacol 198: 211-213 https://doi.org/10.1016/0014-2999(91)90624-Y
- Huang HC, Lee CR, Weng YI, Lee MC, Lee YT (1992) Vasodilator effect of scoparone (6,7-dimethoxycoumarin) from a Chinese herb. Eur J Pharmacol 218: 123-128 https://doi.org/10.1016/0014-2999(92)90155-W
-
Lu C, Li Y, Hu S, Cai Y, Yang Z, Peng K (2018) Scoparone prevents IL-
$1{\beta}$ -induced inflammatory response in human osteoarthritis chondrocytes through the PI3K/Akt/NF-${\kappa}B$ pathway. Biomed Pharmacother 106: 1169-1174 https://doi.org/10.1016/j.biopha.2018.07.062 - Lee DH (2019) Antiplatelet effects of scoparone through up-regulation of cAMP and cGMP on U46619-induced human platelets. J Appl Biol Chem 62: 425-431 https://doi.org/10.3839/jabc.2019.058
- Shin JH, Kwon HW, Lee DH (2019) Ginsenoside F4 inhibits platelet aggregation and thrombus formation by dephosphorylation of IP3RI and VASP. J Appl Biol Chem 62: 93-100 https://doi.org/10.3839/jabc.2019.014
- Chang MC, Wang TM, Yeung SY, Jeng PY, Liao CH, Lin CC, Lin BR, Jeng JH (2011) Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production. Atherosclerosis 219(2): 559-565 https://doi.org/10.1016/j.atherosclerosis.2011.09.031
- Cipollone F, Patrignani P, Greco A, Panara MR, Padovano R, Cuccurullo F Patrono C, Rebuzzi AG, Liuzzo G, Quaranta G, Maseri A (1997) Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation 96: 1109-1116 https://doi.org/10.1161/01.CIR.96.4.1109
- Patrono C (2001) Aspirin: new cardiovascular uses for an old drug. Am J Med 110: 62S-65S https://doi.org/10.1016/S0002-9343(00)00645-8
- Irfan M, Jeong D, Saba E, Kwon HW, Shin JH, Jeon BR, Kim S, Kim SD, Lee DH, Nah SY, Rhee MH (2019) Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling. Platelets 30(5): 589-598 https://doi.org/10.1080/09537104.2018.1479033
- McNicol A, Jackson EC (2003) Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets. Biochem Pharmacol 65(8): 1243-1250 https://doi.org/10.1016/S0006-2952(03)00069-8
Cited by
- 콜라겐-유도의 사람 혈소판에서 PI3K/Akt 및 MAPK 조절을 통한 Isoscopoletin의 항혈소판 효과 vol.51, pp.3, 2020, https://doi.org/10.22889/kjp.2020.51.3.151
- U46619 유도의 혈소판에서 Cyclic Nucleotides 조절을 통한 Isoscopoletin의 혈전생성 억제효과 vol.52, pp.1, 2020, https://doi.org/10.22889/kjp.2021.52.1.26